X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (41946) 41946
Book Review (4726) 4726
Publication (2086) 2086
Conference Proceeding (78) 78
Book Chapter (70) 70
Magazine Article (26) 26
Dissertation (22) 22
Newsletter (16) 16
Book / eBook (8) 8
Paper (8) 8
Newspaper Article (5) 5
Data Set (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (37484) 37484
humans (32889) 32889
female (20815) 20815
antineoplastic combined chemotherapy protocols - therapeutic use (17036) 17036
doxorubicin - administration & dosage (16010) 16010
doxorubicin (15925) 15925
male (15453) 15453
middle aged (13908) 13908
oncology (13484) 13484
adult (11893) 11893
chemotherapy (11118) 11118
aged (10926) 10926
doxorubicin - therapeutic use (10092) 10092
cancer (9925) 9925
animals (9397) 9397
cyclophosphamide - administration & dosage (7323) 7323
treatment outcome (6090) 6090
pharmacology & pharmacy (5855) 5855
vincristine - administration & dosage (5660) 5660
anthracyclines (5407) 5407
mice (5290) 5290
breast neoplasms - drug therapy (4836) 4836
combined modality therapy (4626) 4626
antineoplastic combined chemotherapy protocols - adverse effects (4281) 4281
doxorubicin - pharmacology (4278) 4278
antineoplastic agents - therapeutic use (4237) 4237
cell line, tumor (4236) 4236
doxorubicin - adverse effects (4204) 4204
prognosis (4038) 4038
therapy (3951) 3951
cisplatin - administration & dosage (3848) 3848
drug delivery systems (3733) 3733
antineoplastic combined chemotherapy protocols - administration & dosage (3578) 3578
nanoparticles (3534) 3534
cyclophosphamide - therapeutic use (3519) 3519
adolescent (3507) 3507
breast cancer (3353) 3353
tumors (3280) 3280
prednisone - administration & dosage (3255) 3255
drugs (3244) 3244
vincristine - therapeutic use (3139) 3139
neoplasm staging (3098) 3098
hematology (3082) 3082
apoptosis (3018) 3018
care and treatment (2940) 2940
analysis (2755) 2755
abridged index medicus (2747) 2747
survival rate (2742) 2742
disease-free survival (2698) 2698
aged, 80 and over (2653) 2653
drug administration schedule (2624) 2624
retrospective studies (2598) 2598
breast neoplasms - pathology (2512) 2512
methotrexate - administration & dosage (2485) 2485
cyclophosphamide (2475) 2475
survival analysis (2391) 2391
follow-up studies (2376) 2376
antineoplastic agents - administration & dosage (2345) 2345
cisplatin (2332) 2332
remission induction (2270) 2270
fluorouracil - administration & dosage (2248) 2248
toxicity (2243) 2243
time factors (2224) 2224
dose-response relationship, drug (2198) 2198
rats (2198) 2198
neoplasms - drug therapy (2144) 2144
antineoplastic agents - pharmacology (2142) 2142
prednisone - therapeutic use (2133) 2133
research (2105) 2105
paclitaxel (2097) 2097
vehicles (2097) 2097
survival (2076) 2076
health aspects (2053) 2053
etoposide - administration & dosage (2052) 2052
expression (2034) 2034
child (2017) 2017
chemotherapy, adjuvant (1992) 1992
antibiotics, antineoplastic - administration & dosage (1978) 1978
adriamycin (1957) 1957
in-vitro (1957) 1957
carcinoma (1956) 1956
medicine & public health (1947) 1947
cells (1945) 1945
cell survival - drug effects (1897) 1897
drug therapy (1883) 1883
drug-delivery (1873) 1873
doxorubicin - analogs & derivatives (1862) 1862
antibiotics, antineoplastic - therapeutic use (1833) 1833
liposomes (1805) 1805
drug delivery (1769) 1769
chemistry, multidisciplinary (1750) 1750
lung neoplasms - drug therapy (1736) 1736
drug resistance (1722) 1722
apoptosis - drug effects (1720) 1720
doxorubicin - chemistry (1719) 1719
bleomycin - administration & dosage (1710) 1710
trial (1693) 1693
drug therapy, combination (1682) 1682
cytotoxicity (1655) 1655
prospective studies (1607) 1607
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37971) 37971
Japanese (1788) 1788
German (531) 531
French (435) 435
Chinese (400) 400
Spanish (248) 248
Russian (246) 246
Italian (151) 151
Polish (134) 134
Hungarian (38) 38
Czech (20) 20
Dutch (17) 17
Ukrainian (16) 16
Hebrew (13) 13
Portuguese (12) 12
Korean (10) 10
Croatian (9) 9
Serbian (9) 9
Lithuanian (6) 6
Bulgarian (5) 5
Finnish (4) 4
Swedish (4) 4
Romanian (3) 3
Turkish (3) 3
Norwegian (2) 2
Danish (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, pp. e0181535 - e0181535
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2013, Volume 24, Issue 9, pp. 2278 - 2284
Journal Article
European journal of haematology, ISSN 0902-4441, 2007, Volume 78, Issue Suppl. 67, pp. 5 - 14
The non-Hodgkin's lymphomas (NHLs) comprise a heterogeneous collection of lymphoproliferative malignancies, which are most common in people aged over 55 years.... 
Rituximab | Non-Hodgkin's lymphoma | DOXORUBICIN | PHASE-II | FOLLICULAR LYMPHOMA | CHOP CHEMOTHERAPY | COMBINATION | B-CELL LYMPHOMA | ANTI-CD20 MONOCLONAL-ANTIBODY | non-Hodgkin's lymphoma | LOW-GRADE | RETREATMENT | HEMATOLOGY | ELDERLY-PATIENTS | rituximab | Health aspects | Non-Hodgkin's lymphomas
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2016, Volume 34, Issue 23, pp. 2690 - 2697
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of... 
CELL TRANSPLANT | MEDICINE, GENERAL & INTERNAL | VINORELBINE | MOPP | DISEASE | REGIMEN | IFOSFAMIDE | CHEMOTHERAPY | STANDARD | HYBRID | FERTILITY | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Lymphomas | Hodgkin's disease | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 11/2013, Volume 172, Issue 1, pp. 137 - 143
The ultimate goal of cancer chemotherapy is to achieve a cure without causing any adverse effects. We have developed a pH-sensitive redox nanoparticle (RNP ),... 
Reactive oxygen species | Transcriptional factor | Cancer chemotherapy | Doxorubicin | Nitroxide radical | pH-responsive polymeric micelle | CELLS | OXIDATIVE STRESS | MITOCHONDRIAL-FUNCTION | DRUG-RESISTANCE | ANTITUMOR-ACTIVITY | CHEMISTRY, MULTIDISCIPLINARY | CHEMOTHERAPY | BREAST-CANCER | IN-VIVO | PHARMACOLOGY & PHARMACY | RADICAL-CONTAINING NANOPARTICLES | NF-KAPPA-B | Free Radical Scavengers - pharmacology | Neoplasms - metabolism | Doxorubicin - therapeutic use | Reactive Oxygen Species - metabolism | Antibiotics, Antineoplastic - pharmacology | Nanoparticles - chemistry | Humans | NF-kappa B - immunology | Antibiotics, Antineoplastic - adverse effects | Delayed-Action Preparations - chemistry | Inflammation - drug therapy | Free Radical Scavengers - therapeutic use | Nitrogen Oxides - therapeutic use | Oxidation-Reduction | Free Radical Scavengers - administration & dosage | Nitrogen Oxides - administration & dosage | Inflammation - immunology | Neoplasms - drug therapy | Drug Synergism | Animals | Antibiotics, Antineoplastic - therapeutic use | Neoplasms - immunology | Nitrogen Oxides - pharmacology | Mice | Mice, Inbred BALB C | Doxorubicin - adverse effects | Doxorubicin - pharmacology | Complications and side effects | Anthracyclines | Chemotherapy | Cancer | Creatine kinase | College graduates | Creatine | Index Medicus | Adjuvants
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9828, pp. 1791 - 1799
Summary Background The intensity of chemotherapy and need for additional radiotherapy in patients with advanced stage Hodgkin's lymphoma has been unclear. We... 
Internal Medicine | SURVIVAL | ABVD | MEDICINE, GENERAL & INTERNAL | COMBINATIONS | POSITRON-EMISSION-TOMOGRAPHY | DISEASE | PROGNOSTIC SCORE | RISK | STANFORD-V | PROGRESSION | MOPP/ABV HYBRID | Doxorubicin - therapeutic use | Prospective Studies | Hodgkin Disease - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Positron-Emission Tomography | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Treatment Failure | Hodgkin Disease - drug therapy | Adult | Female | Radiotherapy Dosage | Etoposide - adverse effects | Prednisone - adverse effects | Proportional Hazards Models | Etoposide - therapeutic use | Treatment Outcome | Bleomycin - adverse effects | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Chemotherapy | Usage | Care and treatment | PET imaging | Diagnosis | Hodgkin's disease | Cancer | Medical imaging | Meetings | Patient safety | Oncology | Lymphomas | Histology | Radiation therapy | Ovarian cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2017, Volume 35, Issue 20, pp. 2260 - 2267
Journal Article
Blood, ISSN 0006-4971, 07/2011, Volume 118, Issue 1, pp. 37 - 43
Journal Article
The Lancet, ISSN 0140-6736, 12/2017, Volume 390, Issue 10114, pp. 2790 - 2802
Journal Article